Fibroadenoma epidemiology and demographics

Revision as of 19:13, 29 January 2016 by Haytham Allaham (talk | contribs)
Jump to navigation Jump to search

Fibroadenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibroadenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT Scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fibroadenoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroadenoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroadenoma epidemiology and demographics

CDC on Fibroadenoma epidemiology and demographics

Fibroadenoma epidemiology and demographics in the news

Blogs on Fibroadenoma epidemiology and demographics

Directions to Hospitals Treating Fibroadenoma

Risk calculators and risk factors for Fibroadenoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Epidemiology and Demographics

Prevelance

Incidence

Age

Fibroadenoma commonly affects individuals younger than 30 years of age.

Gender

Race

References

Template:WH Template:WS